We Share retweeted
📢 Start-ups developing new treatments for #hearingloss or #tinnitus across Europe - there is just 1 week left to apply!
The @RNID #HearingTherapeuticsInitiative is proud to support this new @MedDiscCat x @WeShareImpact #funding programme for early-stage #medicinesdiscovery👇
We Share retweeted
Working on an R&D project for infections in cystic fibrosis, hearing loss and tinnitus, or psychiatric disorders?
We’re eager to support your growth!
Apply for funding - deadline fast approaching - 31 December 2021 ⏰ ow.ly/NhZt50Hgbm3 #MDCXWS @WeShareImpact
We Share retweeted
. @MedDiscCat and @WeShareImpact's collaborative #funding programme is aimed at early-stage #medicinesdiscovery in three areas:
• Cystic fibrosis-related infections
• Hearing loss and tinnitus
• Psychiatric disorders
Competition closes: 31st December
More information ⬇️
Applications are still open for our funding programme with @WeShareImpact - on early stage #medicinesdiscovery.
Do you want to create change in the health sector and impact patients lives?
We can support you! Find out how to get involved ⬇️
ow.ly/9Pei50H5WNc #MDCxWS
We Share retweeted
Applications are still open for our funding programme with @WeShareImpact - on early stage #medicinesdiscovery.
Do you want to create change in the health sector and impact patients lives?
We can support you! Find out how to get involved ⬇️
ow.ly/9Pei50H5WNc #MDCxWS
We Share retweeted
Replying to @MedDiscCat
@MedDiscCat and @WeShareImpact have recently begun accepting applications for a grant of up to €300,000📢
This will be to support preclinical-stage R&D that has a clear line of sight to patient impact!
Interested?👇
weshareventures.com/ws-x-mdc…
📢Our funding programme with @WeShareImpact is now open for applications – early-stage medicines discovery start-ups across Europe working in psychiatry, hearing of cystic fibrosis infections, get in touch now ⬇️
ow.ly/p7nw50GPxqM
#wsxmdc #funding
We Share retweeted
Are you a startup working on an R&D project for infections in #cysticfibrosis, #hearingloss and #tinnitus, or #psychiatricdisorders?
Access long-term capital in the early phases of your growth - apply for MDC & @WeShareImpact's funding programme⬇️
ow.ly/kBRF50H1GaT #MDCxWS
We Share retweeted
Funding Programme open for applications. @WeShareImpact & @MedDiscCat have launched a fund for early-stage medicines discovery startups working on Hearing loss/ tinnitus, Psychiatric disorders & Cystic Fibrosis. Deadline: 31 December
>>> ow.ly/LhUj50GXeKP
#funding
Which Sustainable Development Goals are you committing to? Apply for our SDG 3, 9 and 17 focused funding programme!
#MDCXWSFundingPorgramme #venturephilanthropy #impactinvestment #philanthropyworks #sdg3 #WAAW2021
1
With @MedDiscCat, we have opened applications for a funding programme, helping to fund early-stage medicines discovery startups across Europe that are hoping to create patient impact in the three focus areas (Hearing loss/ tinnitus, Psychiatric disorders and Cystic Fibrosis).
For more information, on how to get involved, check out our website: weshareventures.com/wsxmdc/
We Share retweeted
It’s #WAAW2021!
This week, we were delighted to launch our new funding programme with @WeShareImpact.
If you’re an early stage-start up looking for catalytic funding to support your cystic fibrosis antimicrobial development programme, get in touch 📞ow.ly/H1Ij50GRLon
For too long, accessing catalytic funding has been a challenge for medicines discovery startups focused on areas of clinical unmet needs.
1
To combat this, with our new funding programme, we are bringing our innovative revolving funding model together with @MedDiscCat Syndicate’s programme, enabling promising startups in the medicine discovery space to access to long-term capital in the early phases of growth.
For more information, on how to get involved, check out our website: weshareventures.com/wsxmdc/
We Share retweeted
Know a young European startup working on new treatments for hearing loss and tinnitus, that could benefit from non-dilutive support? @MedDiscCat and @WeShareImpact have a new funding model for preclinical-stage medicines discovery - apply before the 31st of December👇
📢Our funding programme with @WeShareImpact is now open for applications – early-stage medicines discovery start-ups across Europe working in psychiatry, hearing of cystic fibrosis infections, get in touch now ⬇️
ow.ly/p7nw50GPxqM
#wsxmdc #funding
We Share retweeted
📢Our funding programme with @WeShareImpact is now open for applications – early-stage medicines discovery start-ups across Europe working in psychiatry, hearing of cystic fibrosis infections, get in touch now ⬇️
ow.ly/p7nw50GPxqM
#wsxmdc #funding
We & @MedDiscCat are thrilled to launch our funding programme, piloting a model aimed at opening new funding opportunities for early-stage medicines discovery in the three key areas! We are accepting applications until the 31st of Dec.
Find more info at: weshareventures.com/wsxmdc/
This funding programme focuses on the following three areas: psychiatric disorders, hearing disorders and infections associated with cystic fibrosis.
#MDCXWSFundingPorgramme
Last chance to join us tomorrow at #ImpactFest2021 @impactcity! Hope to see you at our session from 13:30 until 15:00 at the Fokker Terminal, The Hague.
Buy your tickets here: impactfest.nl/tickets/
1
Few days ago we sent out our quarterly newsletter! To catch up on what we have been up to click on this link: mailchi.mp/5eeb90db8393/news…
Subscribe to receive the following letters and to stay up to date!
#investors4impact #venturephilanthropy #impactinvesting #socialfinance #sdg3

















